This variation does not appear to alter the TNF binding kinetics of TNFR2, but affects TNF-induced apoptosis in adenocarcinoma cervical cancer cells (HeLa cells) through impaired NF-kB signaling and target gene expression [25]. The gene discussed is TNF; the disease is adenocarcinoma.